Cantor Fitzgerald Analysts Give ProQR Therapeutics (PRQR) a $40.00 Price Target - Fairfield Current
Cantor Fitzgerald Analysts Give ProQR Therapeutics (PRQR) a $40.00 Price Target  Fairfield Current

ProQR Therapeutics (NASDAQ:PRQR) received a $40.00 price target from investment analysts at Cantor Fitzgerald in a research report issued on Friday, ...